Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Fermenta Biotech
Join Channel
Consolidated Standalone

Fermenta Biotech

₹159 -2.8 | 1.7%

Market Cap ₹468 Cr.

Stock P/E -23.1

P/B 1.6

Current Price ₹159

Book Value ₹ 100.9

Face Value 5

52W High ₹214

Dividend Yield 0.79%

52W Low ₹ 132.3

Edit Ratio

Fermenta Biotech Research see more...

Overview Inc. Year: 1951Industry: Pharmaceuticals & Drugs

Fermenta Biotech Ltd, previously DIL Ltd, is an India-based enterprise engaged inside the commercial enterprise of pharma, biotechnology, environmental solutions and different investments. The Company manufactures Vitamin D3, different speciality APIs, biological enzymes. It also offers included biotech-based environmental solutions. The Company caters to over 50 countries with a distribution community throughout programs, which includes pharmaceuticals, meals, dietary and dietary supplements, feed, veterinary and rodenticides. It offers enzymes for antibiotic synthesis and commercial programs.

Read More..

Fermenta Biotech Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Fermenta Biotech Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 100 93 96 92 98 55 105 82 57 99
Other Income 2 1 3 4 3 1 1 2 2 3
Total Income 102 94 99 96 101 56 106 84 59 101
Total Expenditure 84 91 78 87 95 65 86 72 71 74
Operating Profit 18 3 21 9 6 -9 21 13 -12 28
Interest 4 4 4 4 5 5 6 5 4 5
Depreciation 6 7 6 7 9 6 6 6 6 6
Exceptional Income / Expenses 0 0 0 0 0 -19 -9 0 -7 0
Profit Before Tax 7 -7 10 -2 -8 -40 -1 2 -29 16
Provision for Tax 3 1 2 0 1 -3 4 0 0 6
Profit After Tax 4 -8 8 -3 -8 -37 -5 2 -29 10
Adjustments 0 0 -0 0 0 0 1 -0 1 -0
Profit After Adjustments 4 -8 8 -3 -8 -37 -4 2 -28 10
Adjusted Earnings Per Share 1.6 -2.8 2.7 -0.9 -2.8 -12.7 -1.3 0.6 -9.6 3.4

Fermenta Biotech Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 117 139 142 155 164 303 405 293 377 399 350 343
Other Income 2 3 0 1 3 11 27 14 8 8 8 8
Total Income 118 142 142 156 167 314 431 307 386 407 358 350
Total Expenditure 94 113 126 135 152 212 269 229 295 336 331 303
Operating Profit 25 30 16 21 15 102 162 79 91 70 26 50
Interest 5 5 5 6 10 14 21 20 19 18 21 20
Depreciation 9 10 9 8 10 12 12 15 20 26 28 24
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 -28 -16
Profit Before Tax 10 14 3 7 -6 76 129 43 52 27 -52 -12
Provision for Tax 4 3 2 4 3 21 11 -16 9 12 2 10
Profit After Tax 6 11 1 3 -8 55 118 60 43 15 -54 -22
Adjustments -2 -3 -0 -4 -3 -21 -0 0 3 0 2 2
Profit After Adjustments 4 8 0 -1 -11 34 117 60 46 15 -51 -20
Adjusted Earnings Per Share 1.5 2.9 0.2 -0.4 -4.2 12.3 42.7 20.6 15.8 5.4 -17.8 -6.9

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -12% 6% 3% 12%
Operating Profit CAGR -63% -31% -24% 0%
PAT CAGR -460% NAN% NAN% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 6% -21% -8% 14%
ROE Average -16% 0% 18% 13%
ROCE Average -5% 5% 14% 12%

Fermenta Biotech Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 127 133 132 130 144 124 251 309 361 372 315
Minority's Interest 20 22 22 26 28 11 0 0 -0 -1 -3
Borrowings 15 25 5 18 40 135 135 102 110 115 84
Other Non-Current Liabilities 4 8 9 6 8 10 -10 -30 21 39 14
Total Current Liabilities 58 71 94 108 86 104 156 195 230 228 229
Total Liabilities 226 259 262 288 307 385 532 576 722 753 639
Fixed Assets 94 87 85 168 90 97 104 129 263 231 238
Other Non-Current Assets 35 58 86 27 113 106 122 163 128 187 127
Total Current Assets 97 114 91 93 104 182 296 284 330 335 274
Total Assets 226 259 262 288 307 385 532 576 722 753 639

Fermenta Biotech Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 8 4 6 3 -11 -14 32 38 -18 2 -2
Cash Flow from Operating Activities 23 14 15 4 2 59 90 34 63 43 117
Cash Flow from Investing Activities -20 -25 -18 -13 7 -101 -97 -44 -42 -26 -56
Cash Flow from Financing Activities -8 13 1 10 -12 89 12 -47 -1 -22 -41
Net Cash Inflow / Outflow -4 2 -2 1 -4 47 6 -57 20 -4 20
Closing Cash & Cash Equivalent 4 6 3 5 -14 32 38 -18 2 -2 18

Fermenta Biotech Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 1.51 2.86 0.17 -0.41 -4.15 12.25 42.68 20.63 15.77 5.35 -17.85
CEPS(Rs) 5.75 7.58 3.46 4.02 0.76 24.42 47.16 25.83 21.78 14.08 -8.77
DPS(Rs) 11.25 5 2.5 1.25 1.25 1.25 1.25 5 2.5 1.25 1.25
Book NAV/Share(Rs) 46.32 48.22 47.83 47.18 52.47 45.22 87.07 105.16 120.84 123.91 104.44
Core EBITDA Margin(%) 19.11 18.41 10.93 12.77 7.22 30.08 33.44 21.95 21.89 15.62 5.29
EBIT Margin(%) 12.68 13.84 5.08 8.31 2.68 29.57 37.05 21.68 18.72 11.27 -8.72
Pre Tax Margin(%) 8.47 10.11 1.98 4.41 -3.34 25.07 31.81 14.82 13.68 6.76 -14.82
PAT Margin (%) 5.39 7.73 0.66 1.72 -4.97 18.1 29.14 20.32 11.27 3.78 -15.3
Cash Profit Margin (%) 13.27 14.64 6.55 7.01 1.26 22.18 32.07 25.44 16.66 10.19 -7.23
ROA(%) 2.91 4.55 0.37 0.99 -2.76 15.85 25.73 10.75 6.56 2.04 -7.69
ROE(%) 5.01 8.47 0.72 2.08 -6 40.79 64.77 21.92 13.05 4.27 -16.26
ROCE(%) 8.72 10.54 3.68 6.18 1.96 33.86 40.16 12.98 12.62 7.5 -5.35
Receivable days 74.45 84.33 95.44 90.86 96.46 68.24 60.55 84.3 66.65 71.03 67.14
Inventory Days 71.39 62.24 56.57 57.38 73.67 54.27 62.62 134.72 140.69 147.34 151.04
Payable days 137.23 106.72 101.8 102.36 126.05 153.37 163.81 228.76 160.9 150.99 131.18
PER(x) 26.88 14.81 294.19 0 0 19.43 6.43 10.31 15.87 38.41 0
Price/Book(x) 0.88 0.88 1.04 1.23 1.22 5.26 3.15 2.02 2.07 1.66 1.02
Dividend Yield(%) 4.61 1.97 0.84 0.36 0.33 0.09 0.15 2.35 1 0.61 1.17
EV/Net Sales(x) 1.07 1.05 1.35 1.59 1.59 2.63 2.16 2.73 2.4 2 1.34
EV/Core EBITDA(x) 5.1 4.94 11.94 11.5 17.71 7.8 5.39 10.2 9.97 11.29 17.82
Net Sales Growth(%) -9.98 19.24 1.88 9.21 6.02 84.41 33.7 -27.61 28.79 5.63 -12.19
EBIT Growth(%) -59.4 30.35 -62.53 77.49 -66.17 1920.41 67.33 -57.64 11.22 -36.4 -167.9
PAT Growth(%) -76.15 71.27 -91.34 184.4 -403.38 766.34 115.01 -49.52 -28.54 -64.59 -455.59
EPS Growth(%) -81.31 89.43 -94.11 -344.55 -907.25 395.11 248.38 -51.65 -23.55 -66.05 -433.26
Debt/Equity(x) 0.38 0.5 0.54 0.7 0.6 1.39 0.87 0.73 0.66 0.66 0.72
Current Ratio(x) 1.65 1.61 0.97 0.86 1.21 1.76 1.9 1.46 1.44 1.47 1.19
Quick Ratio(x) 1.22 1.28 0.74 0.6 0.76 1.27 1.33 0.8 0.73 0.77 0.63
Interest Cover(x) 3.01 3.71 1.64 2.13 0.45 6.57 7.06 3.16 3.72 2.5 -1.43
Total Debt/Mcap(x) 0.43 0.56 0.52 0.57 0.49 0.26 0.28 0.35 0.31 0.39 0.69

Fermenta Biotech Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 59.58 59.58 59.58 59.58 59.58 59.58 62.06 62.06 62.06 62.06
FII 0 0 0 0 0 0 0 0 0 0
DII 0.06 0.06 0.06 0.06 0.01 0 0 0 0 0
Public 40.35 40.35 40.35 40.35 40.41 40.41 37.94 37.94 37.94 37.94
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 150.99 to 131.18days.
  • Company has reduced debt.

Cons

  • Company has a low return on equity of 0% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Fermenta Biotech News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!